Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346214 · ClinicalTrials.gov registry record
Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age
A clinical trial, sponsored by RTI International.
- Completed
- Registry status
- 252
- Enrollment target
NCT02346214: Completed study, sponsored by RTI International.
NCT02346214 is a clinical trial that has completed, run by RTI International. The registered enrollment target is 252 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02346214 has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a novel, highly automated method of gestational age estimation at delivery combining anterior lens capsule vascularity (ALCV) and biophysical parameters appropriate for use in low income countries. The specific aims of the proposed study are: (1) To develop an algorithm to predict gestational age at delivery from 26 to 42 weeks' gestation with ALCV and key biophysical parameters (2)To evaluate the performance of ALCV and biophysical parameter-based gestational age estimates. Specifically, we hypothesize that the accuracy of the predictive algorithm will be comparable to commonly used measures of gestational age dating (±2 days) and have better precision (±14 days) than commonly used measures of gestational age dating.
Primary Outcome
The gestational age is estimated by eye lens vascularity measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-11-30 |
What the finished NCT02346214 record still lists
NCT02346214 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02346214 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02346214 about?
NCT02346214 is a clinical study titled "Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age". The purpose of this study is to develop a novel, highly automated method of gestational age estimation at delivery combining anterior lens capsule vascularity (ALCV) and biophysical parameters appropriate for use in low income countries. The specific aims of the proposed study are: (1) To develop an...
What is the current status of trial NCT02346214?
This trial is currently completed. The enrollment target is 252 participants. The study started on 2016-07. Estimated completion is 2017-11-30.
Who is sponsoring clinical trial NCT02346214?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia